Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Global Bio-chem Technology Group (GBF) is a leading vertically integrated corn-based biochemical manufacturer based in Hong Kong and mainland China. The company specializes in the research, development, and large-scale production of corn-derived products, most notably amino acids such as lysine, threonine, and tryptophan, which are essential for animal nutrition and pharmaceutical applications. Utilizing advanced microbial fermentation technologies, GBF operates one of the world's largest production capacities for lysine. In addition to its core amino acid business, the company produces corn sweeteners, modified starch, and polyols, serving diverse industries including food and beverage, animal feed, and pharmaceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GBF.